hotspot -WSS

hotspot

author：explore 2025-09-06 03:58:20 - browse：8

Christine Kao/STAT

The Food and Drug Administration’s approval on Friday of two gene therapies for sickle cell disease sets up what could be an intense competition between Bluebird Bio, maker of Lyfgenia, and the partnership of Vertex Pharmaceuticals and CRISPR Therapeutics, whose drug is Casgevy.

For the first time, physicians and patients will have a choice of potentially curative treatments for an inherited disease that affects nearly 100,000 Americans.

The Vertex/CRISPR team would seem to have the edge. As the first CRISPR-based therapy, Casgevy has the advantage of being powered by the latest and buzziest biological technology, though some physicians and patients may be more comfortable with the lentiviral vector technology behind Lyfgenia, which dates back to the 1990s — even with a “black box” warning of a risk of blood cancer added to its label.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Some top drug companies are starting to take action on climate

WSS

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Trump team launching legal defense fund to help pay legal bills

What AstraZeneca

HCA says smaller share of spending going to labor

Will an HIV vaccine ever be a reality?

focus

hotspot

explore

At least 13 dead in Texas as scorching temps continue

Flu, Covid vaccination rates decline, new survey data show

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Many immigrants are left out of maternal health programs

After affirmative action ruling, medical educators look to 'holistic review'

Doctors in states that ban abortion can still help patients

Wildfire smoke exposes gaps in outdoor worker protections

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

5 wounded, 2 critically, in Michigan shopping center shooting

focus

Europe is fastest

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Europe is fastest

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Nobel honors Karikó and Weissman's enduring partnership

hotspot

entertainment

knowledge

hotspot